Home › Research › Clinical safety
Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
Kayla Garvey, Kobi Griffith, Emily L. Carter, Wendy Y. Craig, David J. Gagnon, Richard R. Riker, Nicolette Centanni. Mental Health Clinician, 2025-06-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Abstract Introduction Delirium affects nearly half of hospitalized older adults and is associated with prolonged hospitalization, dementia, and death. The behavioral manifestations of delirium are generally managed with antipsychotics, but there is growing interest in alternative medical therapy, including guanfacine. Methods This retrospective cohort study included patients ≥65 years of age admitted to Maine Medical Center between January 2021 and April 2023 and treated with guanfacine for delirium management on a non-ICU unit. Effectiveness outcomes included antipsychotic use and dose as well as a change in positive delirium screen after guanfacine initiation. Safety outcomes included incidence of hypotension, bradycardia, or transfer to ICU. Results A total of 56 patients who received at least 1 dose of guanfacine were evaluated, and 38 patients (68%) with complete data for days −1 to +2 were included in the effectiveness analysis. Before guanfacine initiation, 22/38 patients (58%) were receiving an antipsychotic medication, compared with 18/38 (47%) after guanfacine initiation (p = 0.86). Patients received a median (interquartile range) 6.4 (3.3 to 16) olanzapine equivalents (OE) before guanfacine was initiated and 4.2 (1.7 to 10.0) OE after guanfacine (absolute difference 2.2 OE; relative difference, 34 %; p = 0.8). All 56 patients were included in the safety analysis; 21 (38%) experienced hypotension, and of these, 7 (33%) patients required intervention. Twenty-three (41%) experienced bradycardia while on guanfacine, resulting in 1 patient being transferred to the ICU. Discussion Upon initiation of guanfacine, patients with delirium had a reduction in daily antipsychotic exposure and a decrease in positive delirium screens. However, guanfacine was associated with hypotension and bradycardia.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 56 participants. In this retrospective cohort of 56 hospitalised older adults, guanfacine for delirium management showed no statistically significant difference in antipsychotic use or dose before and after initiation. It is a small study about managing delirium behaviour, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Garvey, K., Griffith, K., Carter, E. L., Craig, W. Y., Gagnon, D. J., Riker, R. R., et al. (2025). Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults. Mental Health Clinician. https://doi.org/10.9740/mhc.2025.06.164
Vancouver
Garvey K, Griffith K, Carter EL, Craig WY, Gagnon DJ, Riker RR, et al. Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults. Mental Health Clinician. 2025. doi:10.9740/mhc.2025.06.164. PMID: 40496004.
BibTeX
@article{garvey2025-40496004,
author = {Garvey, Kayla and Griffith, Kobi and Carter, Emily L. and Craig, Wendy Y. and Gagnon, David J. and Riker, Richard R. and Centanni, Nicolette},
title = {{Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults}},
journal = {Mental Health Clinician},
year = {2025},
doi = {10.9740/mhc.2025.06.164},
pmid = {40496004},
url = {https://doi.org/10.9740/mhc.2025.06.164}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Abstract Introduction Delirium affects nearly half of hospitalized older adults and is associated with prolonged hospitalization, dementia, and death.
- Results A total of 56 patients who received at least 1 dose of guanfacine were evaluated, and 38 patients (68%) with complete data for days −1 to +2 were included in the effectiveness analysis.
- Before guanfacine initiation, 22/38 patients (58%) were receiving an antipsychotic medication, compared with 18/38 (47%) after guanfacine initiation (p = 0.86).
- However, guanfacine was associated with hypotension and bradycardia.
Why it matters
In this retrospective cohort of 56 hospitalised older adults, guanfacine for delirium management showed no statistically significant difference in antipsychotic use or dose before and after initiation. It is a small study about managing delirium behaviour, not about treating, curing or preventing Alzheimer's disease.
Study details
- Study designcohort study
- Participants56
- Evidence strengthModerate
How this study scored 46/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 44 of the 96 points we could judge it on, which is 46 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Mental Health Clinician) |
| Journal's citation record | 0 / 4 | Mental Health Clinician: journal h-index 33 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 56 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Nicolette Centanni holds only 8 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 1 / 3 | Tufts University: institution h-index 1,045 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40496004) |
| Free to read | 2 / 2 | Free to read |
| Points | 44 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 44 of the 96 points we could judge it on is 46 out of 100. |
| Total | 46 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.9740/mhc.2025.06.164
- PubMed: 40496004
- Original source →
- Free full text: Mental Health Clinician →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Clinical safety from nearby years
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.